KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Nu Skin Enterprises (NUS) EBITDA Margin (2016 - 2025)

Nu Skin Enterprises (NUS) has disclosed EBITDA Margin for 17 consecutive years, with 6.28% as the latest value for Q4 2025.

  • Quarterly EBITDA Margin rose 1819.0% to 6.28% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 4.43% through Dec 2025, up 1318.0% year-over-year, with the annual reading at 4.43% for FY2025, 1318.0% up from the prior year.
  • EBITDA Margin hit 6.28% in Q4 2025 for Nu Skin Enterprises, up from 5.94% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 12.13% in Q2 2021 to a low of 28.6% in Q2 2024.
  • Historically, EBITDA Margin has averaged 2.35% across 5 years, with a median of 4.75% in 2022.
  • Biggest five-year swings in EBITDA Margin: crashed -3709bps in 2024 and later soared 3657bps in 2025.
  • Year by year, EBITDA Margin stood at 3.02% in 2021, then surged by 74bps to 5.26% in 2022, then tumbled by -37bps to 3.29% in 2023, then tumbled by -462bps to 11.91% in 2024, then soared by 153bps to 6.28% in 2025.
  • Business Quant data shows EBITDA Margin for NUS at 6.28% in Q4 2025, 5.94% in Q3 2025, and 7.97% in Q2 2025.